People Background Check
Find People:

Keith Neil Haffer, Age 73Canton, SD

Get Report
Known as:
Keith N Haffer Keith Neil Dr Haffer Keith Living Haffer Keith E Haffer Keith K Haffer Keith Hoffer
Related to:
Robert R Otte 68

Keith Haffer Phones & Addresses

Canton, SD

421 Rose Ave, Sherman, SD 57030 (605) 594-6255

Garretson, SD

Lincoln, NE

Amherst, MA

Sioux Falls, SD

Mentions for Keith Neil Haffer

Keith Haffer resumes & CV records

Resumes

Keith Haffer Photo 2

Keith Haffer

Location:
Sioux Falls, South Dakota Area
Industry:
Biotechnology
Keith Haffer Photo 3

President

Location:
Sioux Falls, SD
Industry:
Biotechnology
Work:
Advantage Bio Consultants
President Gsk Jul 1985 - Sep 1992
Director, Virology and Immunology Development Sanofi Apr 1980 - Jul 1984
Manager, Vaccine Development Purdue University Sep 1978 - Apr 1980
Postdoctoral Associate
Education:
University of Massachusetts Amherst 1976 - 1978
Doctorates, Doctor of Philosophy, Immunology, Virology University of Massachusetts Amherst 1974 - 1976
Master of Science, Masters, Immunology, Virology Boston University 1970 - 1974
Keith Haffer Photo 4

President And Chief Strategy Officer

Location:
421 Rose Ave, Garretson, SD 57030
Industry:
Biotechnology
Work:
Braasch Biotech LLC since Jun 2008
President and CSO Advantage Bio Consultants, Inc - Garretson, South Dakota since Jan 1994
President Braasch Biotech Inc Jan 1998 - Nov 2008
President ImmuCell Corporation Oct 2000 - May 2002
Board Member Grand Laboratories Sep 1992 - Apr 1994
Director Strategic Planning and Research SmithKline Beecham Animal Health Jun 1985 - Aug 1992
Director, Virology and Immunology Development Biologics Corporation Aug 1984 - Jun 1985
Project Leader CEVA Laboratories Mar 1980 - Jul 1984
Manager, Avian Vaccine Development and Diagnostic Services Purdue University, School of Veterinary Medicine Sep 1978 - Mar 1980
Research Associate
Education:
University of Massachusetts, Amherst 1976 - 1978
University of Massachusetts, Amherst 1974 - 1976
Boston University Sep 1970 - May 1974
Skills:
Biotechnology, Vaccines, Immunology, Biopharmaceuticals, Life Sciences, Virology, R&D, Laboratory, Technology Transfer, Commercialization, Molecular Biology, Pharmaceutical Industry, Microbiology, Antibodies, Dna, Infectious Diseases, Drug Development, Lifesciences, Veterinary, Protein Chemistry, Biochemistry, Biologics, Product Development, Strategic Planning, Cell Culture, Cell Biology, Glp, Clinical Development, Regulatory Affairs, Drug Delivery, Genomics, Toxicology, Pcr, Pharmacology, Assay Development, Quality Systems, Biosafety, Quality System, Chromatography, Immunoassays, Research, Business Strategy, Management, Technology Commercialization, Expert Witness, Gmp, Drug Discovery, Medical Diagnostics, M&A Advisory Services, International Project Management
Interests:
Social Services
Children
Cooking
Oes
Environment
Education
Photography
Science and Technology
Disaster and Humanitarian Relief
Human Rights
Equine Studies
Animal Welfare
Health
Languages:
French

Publications & IP owners

Us Patents

Chloramphenicol Acetyl Transferase (Cat)-Defective Somatostatin Fusion Protein And Uses Thereof

US Patent:
7943143, May 17, 2011
Filed:
Feb 10, 2010
Appl. No.:
12/703631
Inventors:
Andrew R. Mendelsohn - Sunnyvale CA, US
Keith N. Haffer - Garretson SD, US
James Larrick - Sunnyvale CA, US
Assignee:
Braasch Biotech LLC - Garretson SD
International Classification:
A61K 39/00
US Classification:
4241981, 4241851, 530311
Abstract:
Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.

Chloramphenicol Acetyl Transferase (Cat)-Defective Somatostatin Fusion Protein And Uses Thereof

US Patent:
8367073, Feb 5, 2013
Filed:
Mar 23, 2011
Appl. No.:
13/069592
Inventors:
Andrew R. Mendelsohn - Sunnyvale CA, US
Keith N. Haffer - Garretson SD, US
James Larrick - Sunnyvale CA, US
Assignee:
Braasch Biotech, LLC - Garretson SD
International Classification:
A61K 39/00
US Classification:
4241981, 4241851, 530311
Abstract:
Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.

Methods For Enhanced Somatostatin Immunogenicity In The Treatment Of Obesity

US Patent:
8425914, Apr 23, 2013
Filed:
Jun 24, 2009
Appl. No.:
12/523952
Inventors:
Keith N. Haffer - Garretson SD, US
James Larrick - Sunnyvale CA, US
Andrew R. Mendelsohn - Sunnyvale CA, US
Assignee:
Braasch Biotech LLC - Garretson SD
International Classification:
C07K 14/655
C12N 9/1033
A61K 2039/55566
C07K 2319/00
C07K 2319/31
US Classification:
4241851, 4241981, 4242781, 514909
Abstract:
Compositions and methods are provided for treatment growth hormone and/or insulin-like growth factor 1 deficiency in a patient in need of such treatment. Compositions and methods include novel vaccines that provide immunogenicity for somatostatin and result in the increased release of endogenously produced growth hormone and/or insulin-like growth factor 1.

Chloramphenicol Acetyl Transferase (Cat)-Defective Somatostatin Fusion Protein And Uses Thereof

US Patent:
2009032, Dec 31, 2009
Filed:
Aug 26, 2008
Appl. No.:
12/198579
Inventors:
Andrew R. Mendelsohn - Mountain View CA, US
Keith N. Haffer - Garretson SD, US
James Larrick - Mountain View CA, US
Assignee:
BRAASCH BIOTECH LLC - Garretson SD
International Classification:
A61K 39/00
C12N 9/10
US Classification:
4241851, 435193, 4242801
Abstract:
Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.

Methods For Improving Immunological Response In Vaccinated Animals

US Patent:
2019037, Dec 12, 2019
Filed:
Aug 27, 2019
Appl. No.:
16/552442
Inventors:
- Garretson SD, US
Keith N. Haffer - Garretson SD, US
International Classification:
A61K 39/385
A61K 39/00
Abstract:
A method is provided for increasing an immunological response to a target antigen in an animal by administering an immunogenic amount of a vaccine comprising a polypeptide conjugate comprising the target antigen conjugated to a carrier polypeptide by means of a linker polypeptide which is rich in predicted linear B-cell epitopes.

Methods For Improving Immunological Response In Vaccinated Animals

US Patent:
2016005, Feb 25, 2016
Filed:
Aug 20, 2015
Appl. No.:
14/831602
Inventors:
- Garretson SD, US
Keith N. Haffer - Garretson SD, US
International Classification:
A61K 39/385
A61K 39/00
Abstract:
A method is provided for increasing an immunological response to a target antigen in an animal by administering an immunogenic amount of a vaccine comprising a polypeptide conjugate comprising the target antigen conjugated to a carrier polypeptide by means of a linker polypeptide which is rich in predicted linear B-cell epitopes.

Possible Relatives

Floyd L Haffer  Barbara D Haffer  Keith E Johnston  Keith W Stanfield  Keith K Stanley  Keith E Stansell  Keith C Stanton  Keith N Staples  Keith A Stark  Keith A Whitehead 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.